Fiscal Year:
2010
Title:
THIOAPTAMER CAPTURE FOR ADDICTION-RELEVANT PROTEINS
Agency:
HHS
Contract:
N43DA201000013
Award Amount:
$200,000.00
Abstract:
AM Biotechnologies (AM) will develop renewable thioaptamer protein capture reagents to ten proteins related to drug addiction. Thioaptamers are a type of aptamer containing phosphorodithioate linkages and other modifications that have excellent affinity and specificity for proteins. Because of the unique chemical composition of thioaptamers, they cannot be developed using the Systematic Evolution of Ligands by Exponential (SELEX) amplification method.
Principal Investigator:
Ross Durland
Small Business Information at Submission:
AM BIOTECHNOLOGIES, LLC
12521 Gulf Freeway HOUSTON, TX 77034-4509
EIN/Tax ID:
205252359
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned:
No
Minority-Owned:
No
HUBZone-Owned:
No